4//SEC Filing
QUAY STEVEN C 4
Accession 0000950170-25-073520
CIK 0001488039other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:05 PM ET
Size
5.5 KB
Accession
0000950170-25-073520
Insider Transaction Report
Form 4
QUAY STEVEN C
DirectorCEO10% Owner
Transactions
- Award
Stock Option (right to buy)
2025-05-15+1,366,062→ 1,366,062 totalExercise: $0.99Exp: 2035-05-15→ Common Stock (1,366,062 underlying)
Footnotes (1)
- [F1]The options shall vest on a quarterly basis over 24 months following May 15, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued on May 15, 2025, with an exercise price of $0.99, representing the closing stock price on May 15, 2025.
Documents
Issuer
ATOSSA THERAPEUTICS, INC.
CIK 0001488039
Entity typeother
Related Parties
1- filerCIK 0001008227
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:05 PM ET
- Size
- 5.5 KB